Emerging Indian entrepreneurship in biotechnology and National Innovation System: exploring linkages and prospects
by Sachin Chaturvedi
International Journal of Technology and Globalisation (IJTG), Vol. 5, No. 1/2, 2010

Abstract: The recent expansion of Indian biotechnology industry backed by strong R&D allocations sets the upward movement of the industry on a new growth trajectory intertwined with innovation and entrepreneurship. This is most likely to take off Indian biopharma industry from 'bio-generics' and 'bio-similars' to a higher pedestal where it may develop 'proprietary processes', carving a new niche for the growth of the sector, giving further push to R&D-intensive activities. The issue is how National Innovation System (NIS), which could provide initial manpower and financial support to the sector, responds to the growing specialisation of the Indian biopharma and help evolve new strategies to sustain the growth in the high-end biopharma sector.

Online publication date: Tue, 15-Jun-2010

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Technology and Globalisation (IJTG):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com